$62.62
Firms Covering LeMaitre ; Barrington Research. Michael Petusky ; Jefferies. Michael Sarcone ; JMP Securities. Danny Stauder ; KeyBanc Capital Markets. Brett Fishbin.
Vascular disease isn't going away. Real people continue to fight the progression and complications that result from PAD. We've won many battles but the war ...
BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 ...
Home»Investor Relations ... vascular and portable medical markets. The ... Investor Contact. Andrew Senn, Senior Vice President, Strategy, Business Development and ...
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. LATHAM, N.Y. --(BUSINESS WIRE)--Apr. 1, 2024-- AngioDynamics, Inc. (NASDAQ: ...
The Investor Relations website contains information about Humacyte, Inc.'s business for stockholders, potential investors, and financial analysts.
The Investor Relations website contains information about Silk Road Medical, Inc.'s business for stockholders, potential investors, and financial analysts.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
Stay informed on Medistim's financial performance, including reports, presentations, and shareholder news.
Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with diseases of ...